DR LAB UK LTD

Company Registration Number:
10376378 (England and Wales)

Unaudited micro entity accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 October 2023

End date: 31 July 2024

DR LAB UK LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

DR LAB UK LTD

Company Information

for the Period Ended 31 July 2024




Registered office: 133
Ballards Lane
London
England
N3 1LJ
Company Registration Number: 10376378 (England and Wales)

DR LAB UK LTD

Profit and Loss Account

for the Period Ended 31 July 2024

10 months to
31 Jul 2024
£

2023
£
Turnover 127,500 89,500
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 43,200 ) ( 32,000 )
Staff Costs ( 6,950 ) ( 3,450 )
Depreciation and Writeoffs ( 4,100 ) ( 3,210 )
Other charges ( 2,980 ) ( 2,304 )
Tax on Profit ( 2,420 ) ( 1,950 )
Profit or (Loss) for Period 67,850 46,586

DR LAB UK LTD

Balance sheet

As at 31 July 2024

10 months to
31 Jul 2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 49,600 29,500
Current assets: 4,300 7,850
Prepayments and accrued income: 1,090 360
Creditors: amounts falling due within one year: ( 6,980 ) ( 29,500 )
Net current assets (liabilities): ( 1,590 ) ( 21,290 )
Total assets less current liabilities: 48,010 8,210
Creditors: amounts falling due after more than one year: ( 3,800 ) ( 7,820 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 530 ) ( 295 )
Total net assets (liabilities): 43,680 95
Capital and reserves: 43,680 95

DR LAB UK LTD

Balance sheet continued

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 26 April 2025
And Signed On Behalf Of The Board By:

Name: Yousef Naghdi
Status: Director

The notes form part of these financial statements

DR LAB UK LTD

Footnotes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Employee Information

    Average number of employees: 2

DR LAB UK LTD

Footnotes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Off balance sheet disclosure

    No